cbdMD Inc.

AMEX: YCBD · Real-Time Price · USD
0.76
-0.09 (-10.54%)
At close: Aug 15, 2025, 3:58 PM
0.76
0.03%
After-hours: Aug 15, 2025, 07:32 PM EDT

cbdMD Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
4.75M 5.11M 4.56M 5.17M 4.38M 5.38M 5.71M 6.12M 6.24M 6.09M 7.86M 8.59M 9.63M 9.32M 9.79M 10.56M 11.8M 12.33M
Cost of Revenue
1.79M 1.71M 2.1M 1.77M 1.8M 2.1M 2.16M 2.27M 2.22M 2.52M 2.89M 2.66M 3.19M 4.33M 4.05M 3.37M 3.64M 3.43M
Gross Profit
2.96M 3.4M 2.45M 3.4M 2.58M 3.27M 3.55M 3.85M 4.02M 3.57M 4.97M 5.93M 6.44M 4.99M 5.74M 7.19M 8.16M 8.9M
Operating Income
-485.82K -86.27K -316.56K -382.03K -1.55M -1.07M -15.22M -1.82M -1.4M -4.05M -14.98M -2.35M -5.01M -25.15M -7.01M -6.68M -4.17M -1.76M
Interest Income
n/a 11.4K n/a n/a n/a 418.00 69.53K n/a n/a 29.12K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-480.76K 15.1K -152.8K 459.74K -3.01M -996.5K -15.87M -1.77M -1.34M -3.96M -14.63M -31.63M -4.66M -19.16M -3.16M 1.64M -13.05M -9.73M
Net Income
-1.48M 15.1K -152.8K 459.74K -3.01M -996.5K -15.87M -1.77M 60.56M -4.96M -15.63M -32.63M -4.3M -19.16M -3.03M 1.54M -12.51M -9.4M
Selling & General & Admin
n/a 2.73M 2.76M 3.03M 3.21M 3.25M 2.75M 4.13M 3.92M 5.74M 6.11M 6.14M 9.08M 9.92M 10.33M 11.24M 9.82M 7.95M
Research & Development
n/a 2.95K 22.19K 10.11K 2.1K 4.63K 16.04K 24.57K 56.16K 76.27K 83.12K 113.75K 151.09K 285.42K 362.19K 674.87K 82.03K 303.71K
Other Expenses
3.45M 753.08K -14.48K 750.38K 917.97K 1.37M -3.25M 9.72K 1.44M 1.79M 101.87K 2.03M 2.22M 70.74K 2.06M 1.95M -8.87M -8.5M
Operating Expenses
3.45M 3.49M 2.77M 3.79M 3.78M 4.27M 5.55M 5.67M 5.42M 7.61M 7.87M 8.28M 11.45M 11.96M 12.76M 13.87M 12.32M 10.66M
Interest Expense
7.64K n/a n/a 12.74K 18.4K 418.00 n/a 1.25K 1.95K n/a n/a 1.55K 2.09K 3.23K n/a 2.58K 10.6K 10.39K
Selling & Marketing Expenses
n/a 1M 904.91K 903.49K 979.63K 1.39M 1.8M 1.88M 1.32M 1.91M 2.75M 3.7M 4.56M 4.43M 4.36M 5.28M 4.46M 3.47M
Cost & Expenses
5.24M 5.2M 4.87M 5.56M 5.93M 6.37M 7.71M 7.94M 7.64M 10.13M 10.76M 10.94M 14.64M 16.28M 16.81M 17.24M 15.97M 14.09M
Income Tax Expense
1M 1M n/a n/a 1M n/a 13.6M n/a -61.9M n/a 53.96M n/a -353.16K 3.23K -130K 103K -536K -332K
Shares Outstanding (Basic)
77.84K 4.55M 4.31M 3.59M 2.96M 2.96M 2.96M 2.38M 1.35M 1.34M 1.36M 1.32M 1.31M 1.31M 1.28M 1.26M 1.26M 1.16M
Shares Outstanding (Diluted)
7.78M 4.55M 4.31M 3.59M 2.96M 2.96M 2.96M 2.38M 1.35M 1.34M 1.36M 1.36M 1.32M 1.31M 1.29M 1.28M 1.37M 1.19M
EPS (Basic)
-19.03 -0.22 1.52 -0.15 -1.35 -0.67 -5.36 -0.74 45.00 -3.7 -11.47 -24.76 -3.28 -14.63 -2.36 1.22 -9.93 -8.11
EPS (Diluted)
-1.9 -0.22 1.52 -0.15 -1.35 -0.67 -5.36 -0.74 45.00 -3.7 -11.47 -23.95 -3.27 -14.62 -2.35 1.20 -9.16 -7.91
EBITDA
-485.82K 354.23K 488.14K 1.06M -2.41M -491.67K -2.22M -1.11M -675.1K -3.3M 38.95M -30.92M -3.6M -18.5M -6.72M 2.2M -12.49M -9.18M
EBIT
n/a -86.27K 200.36K 472.48K -2.99M -1.07M -2.21M -1.77M -1.33M -4.05M 38.22M -31.63M -4.66M -19.16M -7.01M 1.64M -13.04M -9.72M
Depreciation & Amortization
n/a 339.14K 76K 585.58K 584.71K 574.16K 954.85K 659.01K 659.75K 654.1K 729.33K 710.39K 1.06M 658.72K 611.89K 557.29K 547.88K 536.74K